Editorial: Drug Industry, Psychopharmacology, and Mental Health Care Needs: Where Do We Go From Here?
R. Segman and A. Weizman p. 71
Editorial: Treatment Gap In Mental Health Care
M.Z. Abramowitz, D. Greenberg and I. Levav p.80
Big Pharma and Health Care: Unsolvable Conflict of Interests between Private Enterprise and Public Health
M. Brezis p.83
Commentary: Big Pharma and Health Care
R.H. Belmaker p.90
Author’s Response
M. Brezis
Is Lithium a Real Teratogen? What Can We Conclude from the Prospective Versus Retrospective Studies? A Review
S. Yacobi and A. Ornoy p.96
Selective Serotonin Reuptake Inhibitor Induced Neonatal Abstinence Syndrome
G. Klinger and P. Merlob p.107
Antipsychotic Treatment in Schizophrenia: The Role of Computerized Neuropsychological Assessment
S. Kertzman, I. Reznik, H. Grinspan, A. Weizman and M. Kotler p.114
Effectiveness and Safety of Adjunctive Antidepressants in the Treatment of Bipolar Depression: A Review
E.V. Harel and Y. Levkovitz p.121
Attitudes, Knowledge and Preferences of the Israeli Public Regarding Mental Health Services
N. Struch, Y. Shereshevsky, A. Baidani-Auerbach, M. Lachman, N. Sagiv, T. Zehavi and I. Levav p.129
Dying in the Psychiatric Ward
A. Doron and S. Mendlovic p.141